by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Recurrent Patellar Displacement; MPFL Interventions: Procedure: MPFL Reconstruction; Procedure: MPFL + MPTL Reconstruction Sponsors: Assiut University Not yet recruiting Conditions: Recurrent Patellar Displacement; MPFL Interventions: Procedure: MPFL...
by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Primary; Sarcoma Interventions: Procedure: biopsy tract resection; Procedure: biopsy tract non-resection Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting Conditions: Primary; Sarcoma Interventions:...
by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Classical Hodgkin Lymphoma Interventions: Biological: CD30+ CAR T-cells; Drug: Bendamustin; Drug: Fludarabine Sponsors: New York Medical College; University of North Carolina; Memorial Sloan Kettering Cancer Center Not yet recruiting Conditions:...
by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Anorexia Nervosa Interventions: Biological: Psychotherapy as usual combined with single dose normal gut microbiota; Other: Psychotherapy treatment as usual (TAU) Sponsors: Haukeland University Hospital; The Dam Foundation Not yet recruiting Conditions:...
by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Communication Interventions: Other: Assertiveness Skills Training Sponsors: Amasya University Recruiting Conditions: Communication Interventions: Other: Assertiveness Skills Training Sponsors: Amasya University...
by palligoelme@gmail.com | May 8, 2026 | Clinical Trials
Conditions: Ulcerative Colitis (UC) Interventions: Drug: 1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab; Drug: 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib; Drug: 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab; Drug: 1: filgotinib...